Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

1.10
+0.03002.80%
Post-market: 1.08-0.0200-1.82%19:37 EST
Volume:73.11K
Turnover:76.37K
Market Cap:13.32M
PE:0.23
High:1.12
Open:1.06
Low:1.01
Close:1.07
52wk High:10.01
52wk Low:0.3750
Shares:12.11M
Float Shares:8.66M
Volume Ratio:0.69
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.87
EPS(LYR):77.74
ROE:--
ROA:-165.52%
PB:-0.67
PE(LYR):0.01

Loading ...

Company Profile

Company Name:
AEON Biopharma
Exchange:
AMEX
Establishment Date:
- -
Employees:
5
Office Location:
5 Park Plaza,Suite 1750,Irvine,California,United States
Zip Code:
92614
Fax:
- -
Introduction:
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.